. Overview We are a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients. Acute Care Product Portfolio ZYNRELEF ZYNRELEF is a dual-acting...
expected 2026-11-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073515 | EDGAR | 69K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-028374 | EDGAR | — |
| 2024-03-12 | 2023-12-31 | 0000950170-24-029951 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010603 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007618 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001564590-21-007841 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001564590-20-007973 | EDGAR | — |
| 2019-02-22 | 2018-12-31 | 0001193125-19-047780 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001193125-18-060951 | EDGAR | — |
| 2017-02-23 | 2016-12-31 | 0001193125-17-054088 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001193125-26-341301 | EDGAR | — |
| 2025-11-04 | 2025-09-30 | 0001193125-25-263618 | EDGAR | 26K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105475 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-063971 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124698 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091764 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-053964 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063714 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042431 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021237 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001564590-22-037047 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028599 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-14 | 0001193125-26-352403 | EDGAR | — |
| 2026-08-10 | 0001193125-26-341300 | EDGAR | — |
| 2026-04-06 | 0001193125-26-142947 | EDGAR | 9K words |
| 2026-02-26 | 0001193125-26-073502 | EDGAR | — |
| 2026-01-09 | 0001193125-26-008631 | EDGAR | — |
| 2025-11-04 | 0001193125-25-263617 | EDGAR | — |
| 2025-10-29 | 0001193125-25-256300 | EDGAR | — |
| 2025-10-15 | 0001193125-25-240253 | EDGAR | — |
| 2025-08-28 | 0000950170-25-112048 | EDGAR | — |
| 2025-08-15 | 0000950170-25-109234 | EDGAR | — |
363 total filings indexed. 331 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000818033 |
| Ticker | HRTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.herontx.com |
| Listed | 1987-08-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HRTX (~200 tokens, structured JSON with cryptographic provenance)